Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: A survey study

BMC Public Health

Volumn 15, Issue 1, 2015, Pages

  Gordon, Nancy P ^a   Green, Beverly B ^b  

^a DIVISION OF RESEARCH   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

Author keywords

Colorectal cancer screening; CRC; Fecal immunochemical test; Patient attitudes

Indexed keywords

DIAGNOSTIC KIT;

AGED; BLOOD EXAMINATION; CALIFORNIA; COLORECTAL NEOPLASMS; DEVICES; DIAGNOSTIC KIT; EARLY CANCER DIAGNOSIS; FECES; FEMALE; HEALTH PROMOTION; HUMAN; MALE; MASS SCREENING; MICROBIOLOGY; MIDDLE AGED; PATIENT ATTITUDE; POSTAL MAIL; QUESTIONNAIRE; UTILIZATION;

AGED; CALIFORNIA; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; HEALTH PROMOTION; HEMATOLOGIC TESTS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; POSTAL SERVICE; REAGENT KITS, DIAGNOSTIC; SURVEYS AND QUESTIONNAIRES;

EID: 84938970136     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-015-1908-x     Document Type: Article

References (35)

1. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2011 Incidence and Mortality Web-based Report. Atlanta, US: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2014. www.cdc.gov/uscs. Accessed 19 January 2015.
2. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):627-37.
3. Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening test use - United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(44):881-8.
4. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89(19):1406-22.
5. Chapple A, Ziebland S, Hewitson P, McPherson A. What affects the uptake of screening for bowel cancer using a faecal occult blood test (FOBt): a qualitative study. Soc Sci Med. 2008;66:2425-35.
6. Jones RM, Woolf SH, Cunningham BS, Johnson RE, Krist AH, Rothemich SF, et al. The relative importance of patient-reported barriers to colorectal cancer screening. Am J Prev Med. 2010;38(5):499-507.
7. Palmer CK, Thomas MC, von Wagner C, Raine R. Reasons for nonuptake and subsequent participation in the NHIS bowel cancer screening programme: A qualitative study. Br J Cancer. 2014;110:1705-11.
8. Cole SR, Zajac I, Gregory T, Mehaffey S, Roosa N, Turnbull D, et al. Psychosocial variables associated with colorectal cancer screening in South Australia. Int J Behav Med. 2011;19:302-9.
9. Gimeno Garcia AZ. Factors influencing colorectal cancer screening participation. Gastroenterol Res Pract. 2012;2012:483417. doi: 10.1155/2012/483417 Epub 2011 Dec 1.
10. Clarke N, Sharp L, Osborne A, Kearney PM. Comparison of uptake of colorectal cancer screening based on faecal immunochemical testing (FIT) in males and females: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014. doi: 10.1158/1055-9965.EPI-14-0774.
11. Inadomi JM, Vijan S, Janz NK, Fagerlin A, Thomas JP, Lin YV, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172(7):575-82.
12. Gupta S, Halm EA, Rockey DC, Hammons M, Koch M, Carter E, et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. 2013;173(18):1725-32.
13. Chubak J, Bogart A, Fuller S, Laing SS, Green BB. Uptake and positive predictive value of fecal occult blood tests: a randomized controlled trial. Prev Med. 2013;57(5):671-8.
14. van Rossum LG, van Rijn AF, Laheij RJ, Verbeek AL, van Oijen MG, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135(1):82-90.
15. Liles EG, Perrin N, Rosales AG, Feldstein AC, Smith DH, Mosen DM, et al. Change to FIT increased CRC screening rates: Evaluation of a US screening outreach program. Am J Manag Care. 2012;18(10):588-95.
16. Beeker C, Kraft JM, Southwell BG, Jorgensen CM. Colorectal cancer screening in older men and women: qualitative research findings and implications for intervention. J Commun Health. 2000;25(3):263-78.
17. McCaffery K, Wardle J, Waller J. Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom. Prev Med. 2003;36(5):525-35.
18. Weitzman ER, Zapka J, Estabrook B, Goins KV. Risk and reluctance: understanding impediments to colorectal cancer screening. Prev Med. 2001;32(6):502-13.
19. Clavarino AM, Janda M, Hughes KL, Del Mar C, Tong S, Stanton WR, et al. The view from two sides: a qualitative study of community and medical perspectives on screening for colorectal cancer using FOBT. Prev Med. 2004;39(3):482-90.
20. Aubin-Auger I, Mercier A, Lebeau JP, Baumann L, Peremans L, Van Royen P. Obstacles to colorectal screening in general practice: a qualitative study of GPs and patients. Fam Pract. 2011;28(6):670-6.
21. Dent OF, Bartrop R, Goulston KJ. Chapuis PH (1983) Participation in faecal occult blood screening for colorectal cancer. Soc Sci Med. 1983;17(1):17-23.
22. O'Sullivan I, Orbell S. Self-sampling in screening to reduce mortality from colorectal cancer: a qualitative exploration of the decision to complete a faecal occult blood test (FOBT). J Med Screen. 2004;11(1):16-22.
23. Hall NJ, Rubin GP, Dobson C, Weller D, Wardle J, Ritchie M, et al. Attitudes and beliefs of non-participants in a population-based screening programme for colorectal cancer. Health Expect. 2013. doi: 10.1111/hex.12157.
24. Jones RM, Devers KJ, Kuzei AJ, Woolf SH. Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am J Prev Med. 2010;38(5):508-16.
25. Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011;33:101-10.
26. Tiro JA, Vernon SW, Hyslop T, Myers RE. Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening among African Americans and Caucasians. Cancer Epidemiol Biomark Prev. 2005;14(12):2855-61.
27. Shokar N, Carlson CA, Weller SC. Factors associated with racial/ethnic differences in colorectal cancer screening. J Am Board Fam Med. 2008;21:414-26.
28. Reynolds LM, Consedine NS, Pizarro DA, Bissett IP. Disgust and behavioral avoidance in colorectal cancer screening and treatment: a systematic review and research agenda. Cancer Nurs. 2013;36(2):122-30.
29. Miles A, Rainbow S, von Wagner C. Cancer fatalism and poor self-rated health mediate the association between socioeconomic status and uptake of colorectal cancer screening in England. Cancer Epidemiol Biomarkers Prev. 2011;20:2132-40.
30. Healthtalkonline.org. The Faecal Occult Blood test for bowel cancer: Why some were reluctant or did not take part. 2012. http://www.healthtalkonline.org/cancer/Bowel-screening/Topic/1388/ Accessed 19 January 2015.
31. Tessaro I, Mangone C, Parkar I, Pawar V. Kowledge, barriers, and predictors of colorectal cancer screening in an Appalachian church population. Prev Chronic Dis. 2006;3(4):1-11.
32. SAS Institute, Inc. SAS/STAT 9.3 User's Guide. SAS Institute Inc: Cary, NC; 2011.
33. Duncan A, Turnbull D, Wilson C, Osborne JM, Cole SR, Flight I, et al. Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study. BMC Public Health. 2014;14:238.
34. Wong MC, Ching JY, Lam TY, Luk AK, Ng SC, Ng SS, et al. Informed choice vs. no choice in colorectal cancer screening tests: a prospective cohort study in real-life screening practice. Am J Gastroenterol. 2014;109(7):1072-9.
35. Levin TR. The importance of choosing colorectal cancer screening tests: comment on "adherence to colorectal cancer screening". Arch Intern Med. 2012;172(7):582-3.